secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sage Therapeutics, Inc. (—)
CIK:        0001597553
Form:       8-K
Filed at:   2024-11-01T23:59:59+00:00
Accession:  0001193125-24-249830
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sage Therapeutics CFO and GC depart as part of workforce reorganization; separation agreements signed
--------------------------------------------------------------------------------

- CFO Kimi Iguchi and GC Anne Marie Cook resigned on Oct 31, 2024, as part of a previously announced workforce reorganization.
- Iguchi receives 12-month salary continuation, COBRA, and a prorated 50% bonus; also enters consulting agreement through Mar 31, 2025, with hourly pay.
- Cook receives similar severance (12-month salary continuation, COBRA, prorated 50% bonus); no consulting agreement.
- Equity awards amended: for Iguchi, vesting continues during consulting and exercise extended to Oct 31, 2025; for Cook, exercise extended to same date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1597553/000119312524249830/0001193125-24-249830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1597553/000119312524249830/d843349d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-249830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer